Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Neptune Technologies & Bioressources, Inc.

Latest From Neptune Technologies & Bioressources, Inc.

Swanson Vision Defense, Se-cure Femarelle: Health And Wellness Industry News

DSM stirs gut health play with BioCare; Strength coach market for Neptune's Omega Drive; Nutranext corporate brand for Wellnext; and more news in brief.

International Denmark

Neptune, Aker BioMarine Bury Patent Hatchet

The firms say their patent cross-licensing agreement ends all outstanding litigation. Aker gets access to Neptune's composition patents for $10m over a period of 15 months, and Neptune has rights to Aker's select krill oil-related patent portfolio for $4m.

Norway Canada

Industry Roundup: Carlyle Backs Pharma Venture, Nutranomics CEO Returns

NSF adds 'next generation' DNA ID service; Dietary Guidelines updated; NPA in anti-internet tax coalition; GNC hires financial communications firm; and more news in brief.

Dietary Supplements Wellness

Device/Diagnostics Quarterly Deal Statistics, Q2 2015

At $1.8 billion, Q2 device financing nearly doubled the Q1 total, mainly from an increase in IPOs and early VC rounds, and acquisitions were slightly higher at $4.7 billion. Diagnostics funding also increased to $784 million from Q1's $597 million, and Danaher's monster $13.8 billion buy of life sciences company Pall headlined the second quarter's $15.6 billion total in diagnostics M&A activity.

Medical Device Deals
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Nutraceuticals
    • OTC, Consumer
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Other Names / Subsidiaries
    • Acasti Pharma Inc.